Niagen Bioscience Raises FY2026 Sales Guidance from $138.982M-$145.299M to $145.299M-$151.616M vs $130.410M Est
Benzinga Newsdesk 3 days ago
NewsGuidance
Niagen Bioscience (NASDAQ:NAGE) raises FY2026 sales outlook from $138.982 million-$145.299 million to $145.299 million-$151.616 million vs $130.410 million estimate.
Niagen Bioscience (NASDAQ:NAGE) raises FY2026 sales outlook from $138.982 million-$145.299 million to $145.299 million-$151.616 million vs $130.410 million estimate.